AMGEVITA

Amgen Canada Inc🇨🇦 Health Canada

Approval Id: 48ef70c4b25e7a8a
Drug Approval Canada Name: AMGEVITA
Product Name: AMGEVITA
Status: Marketed
Status Date: 2021-02-19
Original Market Date: 2021-02-19
Din: 02459302
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364003
Company Name: Amgen Canada Inc
Company Address: 300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4

ADALIMUMAB

50 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

48ef70c4b25e7a8a

Type

Standard